Bryan Giraudo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bryan giraudo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bryan Giraudo Today - Breaking & Trending Today

Gossamer Bio, Inc. (NASDAQ:GOSS) Given Average Recommendation of "Hold" by Analysts

Gossamer Bio, Inc. (NASDAQ:GOSS – Get Free Report) has received an average rating of “Hold” from the six analysts that are presently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price objective […] ....

United States , Bryan Giraudo , Metlife Investment Management , Gossamer Bio Inc , Bridgefront Capital , Swiss National Bank , Vanguard Group Inc , Jpmorgan Chase Co , Gossamer Bio , Get Free Report , Marketbeat Ratings , National Bank , Life Investment Management , Get Free , Tyrosine Kinase , Gossamer Bio Daily , Nasdaq Goss ,

Gossamer Bio, Inc. (NASDAQ:GOSS) Given Average Recommendation of "Hold" by Brokerages

Gossamer Bio, Inc. (NASDAQ:GOSS) Given Average Recommendation of "Hold" by Brokerages
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , Bryan Giraudo , Pricet Rowe Associates Inc , Gossamer Bio Inc , Securities Exchange Commission , Bridgefront Capital , Hong Kong Ltd , Gossamer Bio , Get Free Report , Bio Stock Down , Exchange Commission , Kong Ltd , Quantbot Technologies , Get Free , Tyrosine Kinase , Gossamer Bio Daily ,

Gossamer Bio (NASDAQ:GOSS) Price Target Raised to $10.00

Gossamer Bio (NASDAQ:GOSS – Free Report) had its target price increased by HC Wainwright from $5.00 to $10.00 in a report published on Monday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Gossamer Bio’s Q4 2023 earnings at ($0.17) EPS, FY2023 earnings at ($1.12) EPS, […] ....

United States , Bryan Giraudo , Gossamer Bio Company Profile , Principal Financial Group Inc , Securities Exchange Commission , Acadian Asset Management , Gossamer Bio Inc , Vanguard Personalized Indexing Management , Td Asset Management Inc , Topco Ltd , Gossamer Bio , Free Report , Bio Trading Down , Get Free Report , Exchange Commission , Financial Group , Management Inc , Asset Management , Tyrosine Kinase , Gossamer Bio Daily , Nasdaq Goss , Boost Price Target , Hc Wainwright ,

Gossamer Bio, Inc. (NASDAQ:GOSS) Given Average Recommendation of "Hold" by Brokerages

Gossamer Bio, Inc. (NASDAQ:GOSS – Get Free Report) has earned a consensus recommendation of “Hold” from the six research firms that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year target price among […] ....

Hong Kong , United States , Bryan Giraudo , Gossamer Bio Company Profile , Invesco Ltd , Hong Kong Ltd , Securities Exchange Commission , Gossamer Bio Inc , Gossamer Bio , Get Free Report , Exchange Commission , State Teachers Retirement System , Street Group , Kong Ltd , Get Free , Tyrosine Kinase , Gossamer Bio Daily , Nasdaq Goss ,